At a glance
ClinicalIndex Comparison RecordN/ACompleted· 356 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Time to DMARD Treatment and Actual Work Limitation of Patients With Rheumatoid Arthritis in Turkey
In Brief
An observational study for Rheumatoid Arthritis. Completed, enrolled 356 participants across 21 sites.
Detailed Summary
The objective is to measure time delay from onset of symptoms to diagnosis and time to disease-modifying anti-rheumatic drug treatments in Turkish patients with rheumatoid arthritis. The investigators will also evaluate actual work limitation status of patients and impact of demographic and clinical factors on work limitations in rheumatoid arthritis patients.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsRheumatoid Arthritis
CountriesTurkey (Türkiye)
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2010
First PostedJun 2010
Primary CompletionAug 2011
TodayJul 2026
First PostedJun 15, 2010
Enrollment StartFeb 1, 2010
Primary CompletionAug 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 16.0 years ago